ClinVar Miner

Submissions for variant NM_000492.4(CFTR):c.1825C>T (p.His609Tyr)

dbSNP: rs2116030305
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology RCV002254396 SCV002525539 likely pathogenic Cystic fibrosis; Congenital bilateral aplasia of vas deferens from CFTR mutation 2022-04-20 criteria provided, single submitter clinical testing The c.1825C>T variant is not present in publicly available population databases like 1000 Genomes, Exome Variant Server (EVS), Exome Aggregation Consortium (ExAC), Genome Aggregation Database (gnomAD) and Indian Exome Database. The variant is not present in our in-house exome database. The variant was not previously reported to Clinvar, Human Genome Mutation Database (HGMD) and/or OMIM databases, in any affected individuals. In-silico pathogenicity prediction programs like PolyPhen-2, MutationTaster2, CADD, Varsome etc. predicted this variant to be likely deleterious. The variant is present in a mutational hotspot region of the CFTR gene and an alternative variant in the same amino acid position (His609Arg) was earlier published several times and reported to ClinVar as pathogenic (Accession: VCV000053398.10).
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV004587335 SCV005076990 uncertain significance not specified 2024-04-23 criteria provided, single submitter clinical testing Variant summary: CFTR c.1825C>T (p.His609Tyr) results in a conservative amino acid change located in the ABC transporter-like, ATP-binding domain (IPR003439) of the encoded protein sequence. Two of four in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 232284 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1825C>T in individuals affected with Cystic Fibrosis and no experimental evidence demonstrating its impact on protein function have been reported. A different variant affecting the same codon has been classified as pathogenic by our lab (c.1826A>G, p.His609Arg), supporting as possible critical relevance of codon 609 to CFTR protein function. ClinVar contains an entry for this variant (Variation ID: 1691298). Based on the evidence outlined above, the variant was classified as uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.